Tag Archives: Latest

Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD

The entire JAK inhibitor family of medicines is feeling the ripple effects from a safety signal flagged for Pfizer’s Xeljanz. Now, the first marketed drug in the class is encountering increased scrutiny from the FDA. The FDA has pushed back a decision for Incyte’s application for Jakafi in steroid-refractory chronic graft-versus-host disease (GVHD) by three months, the… Read More »

AstraZeneca vaccine: Risk of developing blood clots broken down by age – MHRA latest

There is a mood of triumphalism in Britain that can be ascribed to the successful vaccine rollout. Restrictions continue to be lifted in accordance with the roadmap laid out by the Prime Minister and overwhelmed hospitals are now in the rearview mirror, the latest data suggests. Despite the rosy picture, fears about the coronavirus vaccines… Read More »

Latest snapshot of the coronavirus impact

LATEST COVID-19 DEVELOPMENTS: * Four new COVID-19 cases have been uncovered among a family in Melbourne’s north, sparking a search for the source of the outbreak. The four new cases snap Victoria’s 86-day streak without a locally acquired case. * People entering Australia could provide their coronavirus vaccination status through a new pre-check-in digital declaration… Read More »